Cervical Lesion Evaluation in Females of Reproductive Age in Ondo Town, Nigeria
Main Article Content
Keywords
Cervical Cancer, Awareness, Cancer Screening, Nigeria.
Abstract
Background: Several African countries, including Nigeria, continue to have a high prevalence of cervical cancer due to a lack of knowledge about screening and prevention measures, with diagnosis most usually confirmed when the prognosis is poorest. This study evaluated the Pap smear pattern and the level of cervical cancer awareness among females of reproductive age in Ondo Town, Nigeria.
Methodology: This cross-sectional study included 102 female participants aged 30 to 54. The stained smears were analyzed and reported using the Bethesda reporting system. A semi-structured questionnaire was used to obtain information from participants, and the data obtained was statistically analysed using ANOVA for variable comparison across groups, with a confidence interval of 95% considered statistically significant and a p-value of less than 0.05 reported.
Results: Findings revealed that 90.2% of the evaluated smears were negative for squamous intraepithelial lesions and malignancy, while low-grade squamous intraepithelial lesions were detected in 7.84% of cases, and reactive cellular changes accounted for 1.96% of the studied population. Additionally, there was a considerable level of awareness regarding cervical cancer (72.5%) and cervical cancer screening (54.9%); however, only 45.1% of the women had ever undergone a Papanicolaou smear, and an even smaller proportion (19.6%) reported routine screening. The low uptake of cervical cancer screening as a routine test may be attributed to the absence of effective, widespread, or systematic cervical cancer screening programs in Ondo town.
Conclusions: There is a significant relationship between age, risk exposure, and development of cervical lesions among participants in this study. Awareness and lifestyle factors are also key determinants of cervical lesion development and the uptake of cervical cancer screening. Although participants demonstrated awareness of cervical cancer, their knowledge of its preventive measures remained limited. It is recommended that health education campaigns be expanded to enhance the uptake of screening services.
References
2. Musa J. The need for societal investment to improve cervical cancer outcomes in Nigeria: A commentary. Afr J Reprod Health. 2017;21(4):17–23.
3. Chidinma AU, Uchenna AA. Prevalence of Cervical Cancer in Enugu State: A Critical Review of 5-year Hospital Data in Enugu State, Southeast Nigeria. Texila Int J Public Heal. 2022;10(4):1–10.
4. Geogr JH, Stewart K, Li M, Xia Z, Adewole SA, Adeyemo O, et al. Modeling spatial access to cervical cancer screening services in Ondo State, Nigeria. Int J Health Geogr. 2020;28(19):1–15.
5. John-Akinola Y, Oluwasanu MM, Oladepo O. Urban Poor Community Settings’ Knowledge and Screening Practices for Cervical Cancer in Ibadan, Nigeria Abstract. JCO Glob Oncol. 2023;7(7):1024–31.
6. Mafiana JJ, Dhital S, Halabia M, Wang X, Wang X. Barriers to uptake of cervical cancer screening among women in Nigeria: a systematic review. Afr Health Sci. 2022;22(2):295–309.
7. Ogunsola OO, Osayi E, Ajayi OA, Ojo TO, Wudiri K, Amoo B. Cervical cancer screening for people living with HIV; experiences from an innovative cervical screening and treatment program in Nigeria. Research Sq. 2023;8(7):1–17.
8. Kani YA, Muhammad Y, Binji A, Iliya S, Adejumo R, Kamilu IM, Isah M. Prevalence of cervical cancer - A 6-year Retrospective Study in Jigawa State, Nigeria Yamuna. World J Biol Pharm Heal Sci. 2020;04(01):59–76.
9. Chan CK, Aimagambetova G, Ukybassova T, Kongrtay K, Azizan A. Human papillomavirus infection and cervical cancer: epidemiology, screening, and vaccination—review of current perspectives. J. Oncol. 2019;2019(1):3257939.
10. Oluwole EO, Mohammed AS, Akinyinka MR, Salako O. Cervical Cancer Awareness and Screening Uptake among Rural Women in Lagos, Nigeria. J Community Med Prim Heal Care. 2017;29(1):81–8.
11. Bhatla N, Aoki D, Nand D, Rengaswamy S. Cancer of the cervix uteri : 2021 update. Int J Gynecol Obs. 2021;155(1):28–44.
12. Eze GU, Obiebi IP, Umuago IJ. Perspectives of cervical cancer and screening practices among staff of a teaching hospital in South-South Nigeria. J Cancer Res Pract. 2018;5(2):67–73.
13. Adejuyigbe FF, Balogun BR, Sekoni AO, Adegbola AA. Cervical cancer and human papilloma virus knowledge and acceptance of vaccination among medical students in Southwest Nigeria. Afr J Reprod Health. 2015;19(1):140–8.
14. Lott BE, Trejo MJ, Baum C, Mcclelland DJ, Adsul P, Madhivanan P, et al. Interventions to increase uptake of cervical screening in sub-Saharan Africa : a scoping review using the integrated behavioral model. BMC Public
Health. 2020;654(20):1–18.
15. Kashyap N, Krishnan N, Kaur S, Ghai S. Risk Factors of Cervical Cancer: A Case-Control Study. Asia-Pacific J Oncol Nurs. 2019;6(3):308–14.
16. Johnson CA, James D, Marzan A, Armaos M. Cervical Cancer: An Overview of Pathophysiology and Management. Semin Oncol Nurs. 2019;35(2):166–74.
17. Ohihoin AG, Okwuraiwe PA, Musa AZ, Olorunfemi G, Onwuamah CK, Ige F, et al. Prevalence and Predictors of High-Risk HPV in Nigeria. Sci Res Publ. 2022;12(4):745–57.
18. Fernandes A, Viveros- Carreno D, Hoegl J, Avila M, Pareja R. Human papillomavirus- independent cervical cancer. Int J Gynaecol cancer. 2022;32(4):1–7.
19. Ashar H, Kusrini I, Musoddaq A, Asturiningtyas IP. First sexual intercourse and high parity are the most influential factors of precancerous cervical lesions. Maj Obstet Ginekol. 2020;28(3):113.
20. Shrestha AD, Neupane D, Vedsted P, Kallestrup P. Cervical cancer prevalence, incidence and mortality in low and middle income countries: A systematic review. Asian Pacific J Cancer Prev. 2018;19(2):319–24.
21. Olubodun T, Odukoya OO, Balogun MR. Knowledge, attitude, and practice of cervical cancer prevention, among
women residing in an Urban slum in Lagos, South West, Nigeria. Pan Afr Med J. 2019;32:1–10.
22. Amu EO, Ndugba SC, Olatona FA. Knowledge of Cervical Cancer and Attitude to Cervical Cancer Screening among Women in Somolu Local Government Area, Lagos, Nigeria. J Community Med Prim Heal Care. 2019;31(1):76–85.
23. Stella NN. Effect of Age and Parity on Practice of Cervical Cancer Screening Among Women of Child Bearing Age in Anambra State. Glob J Cancer Case Reports. 2021;02(02):83–92.
24. Awodele O, Adeyomoye AA, Awodele DF. Cancer distribution pattern in south-western Nigeria. Tanzan J Health Res. 2015;13(2):1–7.
25. Kamal M. Pap Smear Collection and Preparation:Key Points. Cytojournal. 2022;19(24):1–14.
26. Sathawane P, Kamal MM, Deotale PR, Mankar H. Nuances of the Papanicolaou stain. Cytojournal. 2022;43(19):1–14.
27. Sowunmi A, Alabi A, Fatiregun O, Olatunji T, Okoro U, Durosinmi Etti A. Trend of cancer incidence in an oncology center in Nigeria. West African J Radiol. 2018;25(1):52.
28. Sachan P, Singh M, Patel M, Sachan R. A Study on Cervical Cancer Screening Using Pap Smear Test and Clinical Correlation. Asia-Pacific J Oncol Nurs. 2018;5(3):337–41.
29. Alrajjal A, Pansare V, Saha M, Choudhury R, Yousufuddin M, Khan A. Squamous intraepithelial lesions ( SIL : LSIL , HSIL , ASCUS , ASC-H , LSIL-H ) of Uterine Cervix and Bethesda System. Cytojournal. 2021;18(16):1–24.
30. Gothwal M, Nalwa A, Singh P, Yadav G, Bhati M, Samriya N. Role of Cervical Cancer Biomarkers p16 and Ki67 in Abnormal Cervical Cytological Smear. J Obstet Gynecol India. 2020;71(1):72–7.
31. Chris-ozoko L, Oyem J, Ekanem V. 5-Year Retrospective Study of the Prevalence of Cervical Lesions at the University of Benin Teaching Hospital , Nigeria. Acta Sci Anat. 2020;1(4):235–43.
32. Ducray JF, Kell CM, Basdav J. Cervical cancer knowledge and screening uptake by marginalized population of women in inner-city Durban , South Africa : Insights into the need for increased health literacy. Women’s Heal.
2021;17:1–10.
33. Thushara K, Rupashree S. A Study on Pattern of Pap Smear Abnormalities with Respect to Age : Screening for Cervical Cancer. Galore Int J Heal Sci Res. 2020;5(1):98–103.
34. St-martin G, Thamsborg LH, Andersen B, Christensen J, Ejersbo D, Jochumsen K, et al. Management of low-
grade cervical cytology in young women . Cohort study from Denmark Management of low-grade cervical cytology in young women . Cohort study. Acta Oncol (Madr). 2021;60(4):444–51.
35. David-west G, Clare CA. A Review of Cervical Cancer: Incidence and Disparities. J Natl Med Assoc. 2020;112(2):229–32.
36. Gothwal M, Singh P, Elhence P, Yadav G, Sharma C, Samriya N. Spectrum of Abnormal Cervical Lesions and its Cytohistological Correlation: a Study from an Institute of National Importance of Western Rajasthan. MEDICA- a J Clin Med. 2022;17(3):636–40.
37. Bai H, Liu J, Wang Q, Feng Y, Lou T, Wang S, et al. Oncological and reproductive outcomes of adenocarcinoma in situ of the cervix managed with the loop electrosurgical excision procedure. BMC Cancer. 2018;18(461):4–9.
38. Schwock J, Starova B, Khan ZF, Mirkovic J, Ko HM, Rouzbahman M, et al. Cytomorphologic Features of Gastric-Type Endocervical Adenocarcinoma in Liquid-Based Preparations. Acta Cytol. 2020;65(1):56–66.
39. Taku O, Businge CB, Mdaka ML, Phohlo K, Basera W, Garcia-jardon M, et al. Human pillomavirus prevalence and risk factors among HIV-negative and HIV-positive women residing in rural Eastern. Int J Infect Dis. 2020;95(0):176–
82.
40. Assefa T, Arefaynie M, Mebratu W, Mohammed A, Addisu E. Determinants of cervical cancer screening utilization among women attending health facilities of Dessie town , Northeast Ethiopia. BMC Cancer. 2022;22(1330):1–8.
41. Kyrgiou M, Arbyn M, Bergeron C, Bosch FX, Dillner J, Jit M, et al. Cervical screening : ESGO-EFC position paper of the European Society of Gynaecologic Oncology ( ESGO ) and the European Federation of Colposcopy ( EFC ). Br J Cancer. 2020;123(4):1–8.
42. Delam H, Izanloo S, Bazrafshan M-R, Eidi A. Risk Factors for Cervical Cancer : An Epidemiological Review. J Heal Sci Surveill Syst. 2020;8(3):105–9.
43. Tekalegn Y, Sahiledengle B, Woldeyohannes D, Atlaw D, Degno S, Desta F, et al. High parity is associated with increased risk of cervical cancer: Systematic review and meta-analysis of case–control studies. Women’s Heal. 2022;18.
44. Agustiansyah P, Sanif R, Nurmaini S. Epidemiology and Risk Factors for Cervical Cancer. Biosci Med J Biomed Transl Res. 2021;5(7):624–31.
45. Elson DA, Riley RR, Lacey A, Thordarson G, Talamantes FJ, Arbeit JM. Sensitivity of the cervical transformation zone to estrogen-induced squamous carcinogenesis. Cancer Res. 2000;60(5):1267–75.
46. Brake T, Lambert PF. Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model. Proc Natl Acad Sci U S A. 2005;102(7):2490–5.
47. Schüler S, Ponnath M, Engel J, Ortmann O. Ovarian epithelial tumors and reproductive factors: A systematic review. Arch Gynecol Obstet. 2013;287(6):1187–204.
48. Gaudet MM, Carter BD, Hildebrand JS, Patel A V., Campbell PT, Wang Y, et al. Associations of parity and age at first pregnancy with overall and cause-specific mortality in the Cancer Prevention Study II. Fertil Steril. 2017;107(1):179-188.
49. Fujita M, Tase T, Kakugawa Y, Hoshi S, Nishino Y, Nagase S, et al. Smoking, earlier menarche and low parity as independent risk factors for gynecologic cancers in Japanese: A case-control study. Tohoku J Exp Med. 2008;216(4):297–307.
50. Gierisch JM, Coeytaux RR, Urrutia RP, Havrilesky LJ, Moorman PG, Lowery WJ, et al. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: A systematic review. Cancer Epidemiol Biomarkers Prev. 2013;22(11):1931–43.
51. Asthana S, Busa V, Labani S. Oral contraceptives use and risk of cervical cancer—A systematic review & meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2020;247:163–75.
52. Walboomers J. M. M, Marcel V. Jacobs, M. Michele Manos, F. Xavier Bosch, J. Alain Kummer, Keerti V. Shah, Peter J. F. Snijders, Julian Peto, Chris J. L. M. Meijer NM. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol J Pathol. 1999;189:12–9.
53. Asiaf A, Ahmad ST, Mohammad SO, Zargar MA. Review of the current knowledge on the epidemiology, pathogenesis, and prevention of human papillomavirus infection. Eur J Cancer Prev. 2014;23(3):206–24.
54. Tiiti TA, Selabe SG, Bogers J, Lebelo RL. High prevalence of and factors associated with human papillomavirus infection among women attending a tertiary hospital in Gauteng Province , South Africa. BMC Cancer. 2022;22(854):1–12.
55. Ezechi O, Akinsolu F, Salako A, Abodunrin O, Adewole I, Olagunju M, et al. High-risk human papillomavirus infection among Nigerian women: A systematic review and meta-analysis. J Int Med Res. 2023;51(7):1–17.
56. Toye MA, Okunade KS, Roberts AA, Salako O, Oridota ES, Onajole AT. Knowledge, perceptions and practice of cervical cancer prevention among female public secondary school teachers in Mushin local government area of Lagos State, Nigeria. Pan Afr Med J. 2017;28:1–8.
57. Rimande-Joel R, Ekenedo GO. Knowledge, belief and practice of cervical cancer screening and prevention among women of Taraba, North-East Nigeria. Asian Pacific J Cancer Prev. 2019;20(11):3291–8.
58. Uchendu I, Hewitt-Taylor J, Turner-Wilson A, Nwakasi C. Knowledge, attitudes, and perceptions about cervical cancer, and the uptake of cervical cancer screening in Nigeria: An integrative review. Sci African. 2021;14:e01013. Available from: https://doi.org/10.1016/j.sciaf.2021.e01013
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This is an open-access journal and articles are distributed under the terms of the Creative Commons Attribution Non-Commercial Share-Alike License 4.0. This licence allows users to download and share, remix, tweak and build upon the article for non-commercial purposes, so long as the original authorship is acknowledged and the new creations are licensed under identical terms.